R&D Trajectory-based diagnostics enable early intervention in pr... Diagnostic testing in modern medicine remains largely episodic and threshold-based.
R&D Advancements in early detection and innovative therapies tar... Alzheimer’s disease (AD) robs millions of individuals of their memories, cognitive function, and independence, placing an immense emotional and financial burden on families and healthcare s
News CE marked certification for AI stroke software, Methinks Methinks announces CE marked certification of its medical imaging software for stroke.
News AstraZeneca, MSD raise prostate cancer awareness with 'Never... A new global prostate cancer awareness campaign developed by biopharmaceutical companies AstraZeneca (AZ) and Merck & Co.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
